rosiglitazone has been researched along with Bone Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, ZF; Guo, ZR; Li, PP; Liu, Q; Shen, ZF | 1 |
| Spangler, JG | 1 |
2 other study(ies) available for rosiglitazone and Bone Neoplasms
| Article | Year |
|---|---|
Synthesis and anti-diabetic activity of (RS)-2-ethoxy-3-{4-[2-(4-trifluoro-methanesulfonyloxy-phenyl)-ethoxy]-phenyl}-propionic acid.
Topics: Animals; Arylsulfonates; Blood Glucose; Bone Neoplasms; Cell Line, Tumor; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Mice; Mice, Inbred ICR; Molecular Structure; Osteosarcoma; Phenylpropionates; PPAR alpha; PPAR-beta; Pyrimidines; Rosiglitazone; Thiazolidinediones; Triglycerides | 2006 |
Bone biology and physiology: implications for novel osteoblastic osteosarcoma treatments?
Topics: Bone Neoplasms; Bone Remodeling; Caffeine; Calcium; Cell Line, Tumor; Cyclic AMP; Cytokines; Humans; Models, Biological; Nicotine; Osteoblasts; Osteosarcoma; Receptors, Adrenergic; Receptors, Glutamate; Rosiglitazone; Thiazolidinediones | 2008 |